Cerro-Herreros, E., González-Martínez, I., Moreno, N., Espinosa-Espinosa, J., Fernández-Costa, J., Colom-Rodrigo, A., . . . Artero, R. (2021). Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy. Cell Press.
Chicago-referens (17:e uppl.)Cerro-Herreros, E., et al. Preclinical Characterization of AntagomiR-218 as a Potential Treatment for Myotonic Dystrophy. Cell Press, 2021.
MLA-referens (9:e uppl.)Cerro-Herreros, E., et al. Preclinical Characterization of AntagomiR-218 as a Potential Treatment for Myotonic Dystrophy. Cell Press, 2021.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.